Clarithromycin/Lansoprazole/Amoxicillin

克拉霉素/兰索拉唑/阿莫西林

Report date: 2026/03/04 20:01:44

Base Information

Drug NameClarithromycin/Lansoprazole/Amoxicillin
Drug Alias NamePrevpacLansap
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionProton pump inhibitors50S ribosomal subunit inhibitorsBacterial penicillin-binding protein inhibitors
Targets50S ribosomal subunitProton pumpBacterial penicillin-binding protein
Therapy Area/IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[6] 
Global Approved IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/12/02
Country/TerritoryUnited StatesJapan
CombinationsYes ClarithromycinAmoxicillinLansoprazole
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesTakeda Pharmaceuticals USA Inc
Active IndicationsHelicobacter pylori infectionPurpura, Thrombocytopenic, IdiopathicStomach Ulcer +[5] 
Inactive IndicationsDuodenal Ulcer

Other Information

ATC CodeA02BD07
Related LinksN/A